NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Gauthier K, Bai A, Perras C, et al. Denosumab, Raloxifene, and Zoledronic Acid for the Treatment of Postmenopausal Osteoporosis: Clinical Effectiveness and Harms [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2012 Feb.

Cover of Denosumab, Raloxifene, and Zoledronic Acid for the Treatment of Postmenopausal Osteoporosis: Clinical Effectiveness and Harms

Denosumab, Raloxifene, and Zoledronic Acid for the Treatment of Postmenopausal Osteoporosis: Clinical Effectiveness and Harms [Internet].

Show details

APPENDIX 5CRITICAL APPRAISAL OF INDIVIDUAL STUDIES

Download PDF (95K)

Copyright © CADTH (February 2012)
Bookshelf ID: NBK169520
PubReader format: click here to try

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (750K)

Other titles in this collection

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...